This publication is a
complete source of fresh data and valuable analysis of essential aspects of the
market for generic and innovative medicines in Ukraine. It investigates
changing legalities related to the patent process, exclusivity of data and
reimbursement and pricing issues.
The report features
operational and financial profiles of the selected leading generic and
innovative drug companies operating on the Ukrainian market and provides the
latest on top-selling preparations and forecasts for growth to 2019.
It also analyses the most
influential recent and anticipated market trends and events.
This report provides essential market knowledge, using:
- Discussion of the pricing and future reimbursement issues for generic and innovative medicines in Ukraine
- Examination of upcoming changes to prices and possible reimbursements for these preparations
- Market forecasts for overall development and for each segment over the next five years
- Value data describing Ukraine’s generic and innovative drugs market
- Analysis of data exclusivity and patent expiration regulations
- Analysis of market share occupied by these segments.
Explore key issues on the
Ukrainian market for generic and innovative drugs. Report forecasts market
development, analyses regulatory changes to 2019.
- Which are the most influential manufacturers of generic and innovative drugs for the Ukrainian market?
- What reimbursement policies will most likely influence this market in the near future?
- Which data exclusivity rules apply to the Ukrainian market for generic and innovative drugs?
- What is the current and forecast value of this market and its major segments?
- What are the forecasts for market conditions in Ukraine over the next six years?
Generic and innovative drugs
market in Ukraine, development forecasts for 2014-2019 answers these questions
along with many others. This publication, compiled by publisher’s team of
experienced professionals, offers business information for use in a variety of
vital tasks, from evaluating growth prospects to building a more attractive
product portfolio.
The report examines changes
in the value of the market and major segments from 2009-2014, studies the
market share of the Ukrainian pharmaceuticals market currently held by generic
and innovative medicines and provides in depth forecasts for market growth and
transformation in the years ahead.
The document scrutinises
regulations that currently govern pricing and reimbursement of generic and
innovative drugs in Ukraine, supplies VAT rates and describes the changes
expected with regard to the establishment of the system of the reimbursement.
It provides descriptions of the data exclusivity and patent expiration rules
and offers analyses of the results of recent changes to industry regulations.
Profiles of top generic and
innovative drug producers in Ukraine describe the size, earnings and prospects
for each company. Best selling products in each category are named, and patient
and physician preferences with regard to generic and innovative medicines are
supplied.
Whether businesspeople
involved in this industry need to review market regulations particular to Ukraine,
check on reimbursement procedures and upcoming changes or estimate demand or
growth potential of this market – they will find the informational support
needed in this valuable document. It is a remarkable asset when taking business
decisions with implications that reach far into the future, such as whether to
launch a new business or add a new product line.
Generic and innovative drugs
market in Ukraine, development forecasts for 2014-2019 is typically utilised by
businesses assessing the market for possible entry, current producers and
distributors of generic and innovative drugs for the Ukrainian market and a
variety of investment and financial service professionals. Research and
consulting professionals also avail themselves of its advantages, along with
academic and government institutions, trade and commerce-oriented organizations
and business consultants.
Spanning over 100 pages, “Generic and innovative drugs market in Ukraine 2014: Development
forecasts for 2014-2019” report covering the Methodology, Characteristics
of generic and innovative drugs markets in CIS countries, Generic and
innovative drugs market in Ukraine, Best-selling drugs, Reimbursement and
pricing policies, Key players, Profiles of key manufacturers.
Know
more about this report at – http://mrr.cm/ZKr
Find all Pharma
and Healthcare Report at: - http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.